Michel P Coleman

6PUBLICATIONS
33CO-AUTHORS
Predictive and prognostic markersMolecular and organic electronicsNanophotonicsMedical infection agents (incl. prions)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 20, 2026
Trends in net survival for patients with brain tumors in Japan, 2000-14 (CONCORD-3).

Laureline Gatellier, Melissa Matz, Hiromi Sugiyama

|Sep 17, 2024
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production.

James R Tribble, Melissa Jöe, Carmine Varricchio

|Jul 24, 2024
NMNAT2 is a druggable target to drive neuronal NAD production.

James R Tribble, Melissa Jöe, Carmine Varricchio

|Oct 31, 2023
Microglia-mediated demyelination protects against CD8<sup>+</sup> T cell-driven axon degeneration in mice carrying PLP defects.

Janos Groh, Tassnim Abdelwahab, Yogita Kattimani

|Oct 07, 2022
Axon Biology in ALS: Mechanisms of Axon Degeneration and Prospects for Therapy.

Michael P Coleman

|Mar 11, 2020
Programmed axon degeneration: from mouse to mechanism to medicine.

Michael P Coleman, Ahmet Höke

Pageof 1